OppenheimerFunds’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $230M | Buy |
1,443,145
+4,721
| +0.3% | +$751K | 0.29% | 91 |
|
|
2018
Q4 | $138M | Sell |
1,438,424
-145,196
| -9% | -$13.9M | 0.2% | 122 |
|
|
2018
Q3 | $224M | Sell |
1,583,620
-14,547
| -0.9% | -$2.05M | 0.26% | 103 |
|
|
2018
Q2 | $250M | Buy |
1,598,167
+34,389
| +2% | +$5.38M | 0.3% | 89 |
|
|
2018
Q1 | $252M | Buy |
1,563,778
+84,247
| +6% | +$13.6M | 0.31% | 84 |
|
|
2017
Q4 | $244M | Sell |
1,479,531
-314,473
| -18% | -$51.8M | 0.29% | 87 |
|
|
2017
Q3 | $112M | Buy |
1,794,004
+8,364
| +0.5% | +$521K | 0.14% | 170 |
|
|
2017
Q2 | $142M | Buy |
1,785,640
+6,401
| +0.4% | +$510K | 0.18% | 148 |
|
|
2017
Q1 | $126M | Sell |
1,779,239
-156,836
| -8% | -$11.1M | 0.15% | 166 |
|
|
2016
Q4 | $98.9M | Buy |
1,936,075
+20,201
| +1% | +$1.03M | 0.13% | 194 |
|
|
2016
Q3 | $88.2M | Buy |
1,915,874
+1,145,717
| +149% | +$52.8M | 0.11% | 216 |
|
|
2016
Q2 | $23.2M | Buy |
770,157
+20,591
| +3% | +$620K | 0.03% | 515 |
|
|
2016
Q1 | $24M | Buy |
+749,566
| New | +$24M | 0.03% | 505 |
|